Literature DB >> 10073815

Usefulness of the presenting electrocardiogram in predicting successful reperfusion with streptokinase in acute myocardial infarction.

C K Wong1, J K French, P E Aylward, M J Frey, A A Adgey, H D White.   

Abstract

The presenting electrocardiogram may contain information indicating the probability of successful reperfusion. The relation between 3 parameters in the presenting electrocardiogram (pathologic Q waves, T-wave inversion, and the slope of ST elevation) and Thrombolysis in Myocardial Infarction trial (TIMI) grade 3 flow in the infarct-related artery was assessed angiographically 90 minutes after beginning streptokinase in 362 patients. TIMI grade 3 flow was more common in patients without Q waves (55%) than in those with Q waves (35%; p <0.001), and more common in patients without T-wave inversion (50%) than in those with T-wave inversion (30%; p <0.002). There was no relation between the slope of the ST segment or the magnitude of its deviation and the achievement of TIMI grade 3 flow. Only 20% of the 59 patients with both Q waves and T-wave inversion had TIMI grade 3 flow, compared with 50% of the remaining patients (p <0.0001). Among patients treated within 3 hours, TIMI grade 3 flow was seen in 68% of those without versus 44% of those with Q waves (p <0.01), and in 62% of those without versus 43% of those with T-wave inversion (p = 0.06). Among patients treated after 3 hours, TIMI grade 3 flow was seen in 38% of those without versus 30% of those with Q waves (p = NS), and in 38% of those without versus 23% of those with T-wave inversion (p <0.05). On multivariate analysis, the absence of Q waves, the time from the onset of chest pain to treatment, and age were independent predictors of TIMI grade 3 flow. Pathologic Q waves in the presenting electrocardiogram provide valuable information as to the probability of achieving successful reperfusion following administration of streptokinase, and may be helpful for triage of patients to alternative reperfusion strategies, including percutaneous revascularization.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10073815     DOI: 10.1016/s0002-9149(98)00818-2

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  7 in total

Review 1.  The use of the electrocardiogram to identify epicardial coronary and tissue reperfusion in acute myocardial infarction.

Authors:  M Vaturi; Y Birnbaum
Journal:  J Thromb Thrombolysis       Date:  2000-10       Impact factor: 2.300

Review 2.  The electrocardiogram in ST elevation acute myocardial infarction: correlation with coronary anatomy and prognosis.

Authors:  Y Birnbaum; B J Drew
Journal:  Postgrad Med J       Date:  2003-09       Impact factor: 2.401

Review 3.  Nanoscale science: a big step towards the Holy Grail of single molecule biochemistry and molecular biology.

Authors:  R C Doty; D G Fernig; R Lévy
Journal:  Cell Mol Life Sci       Date:  2004-08       Impact factor: 9.261

4.  Comparison of the prognostic role of Q waves and inverted T waves in the presenting ECG of STEMI patients.

Authors:  Kimmo Koivula; Kjell Nikus; Juho Viikilä; Jyrki Lilleberg; Heini Huhtala; Yochai Birnbaum; Markku Eskola
Journal:  Ann Noninvasive Electrocardiol       Date:  2018-09-06       Impact factor: 1.468

Review 5.  [Enzymatic markers of reperfusion in acute myocardial infarct. With data from the ISAM study].

Authors:  S Walter; J Carlsson; R Schröder; K L Neuhaus; E Sorges; U Tebbe
Journal:  Herz       Date:  1999-10       Impact factor: 1.443

6.  Terminal QRS distortion and severity of coronary artery disease in ST-elevation myocardial infarction.

Authors:  E M Bakirci; K Kalkan; H Hamur; M Buyuklu; M Cetin; H Degirmenci; H Duman; Z Kucuksu; I H Tanboga; E Topal
Journal:  Herz       Date:  2014-01-19       Impact factor: 1.443

Review 7.  The use of the electrocardiogram to identify epicardial coronary and tissue reperfusion in acute myocardial infarction.

Authors:  M Vaturi MD; Y Birnbaum MD
Journal:  J Thromb Thrombolysis       Date:  2000-08       Impact factor: 2.300

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.